Sen. Sheldon Whitehouse

Maddy summaryS 1843, the Second Chance Reauthorization Act of 2025, extends funding for existing federal reentry programs through 2030 instead of 2023. It updates timeframes across multiple programs, including state reentry demonstration projects (adding substance use disorder treatment and housing services), family-based substance abuse grants, prison education evaluations, career training for incarcerated individuals, and community mentoring programs. These programs directly support people returning from incarceration by providing critical services like recovery support, job training, and transitional housing. The bill makes no new policy changes but continues current federal funding mechanisms for reentry assistance.

Maddy summaryThis bill creates a tax credit for businesses that capture and store carbon from forest residues used in wildfire hazard reduction activities. The credit provides $36 per metric ton for carbon stored in secure geological storage and $12 per metric ton for carbon stored through long-duration utilization. To qualify, businesses must meet sustainability standards for sourcing forest residues (from thinning trees no greater than 8 inches in diameter) and undergo verification through lifecycle analysis and monitoring. The credit is designed to incentivize carbon removal while promoting sustainable forest management practices. It will apply to taxable years beginning after December 31, 2025.

Maddy summaryThe SMART Prices Act (S 1836) changes how Medicare negotiates drug prices. It increases the number of drugs eligible for negotiation from 15 to 50 per year starting in 2028, shortens the time drugs must be the sole source for eligibility from 7 to 3 years, and adjusts price ceiling percentages for negotiated drugs (e.g., raising the maximum fair price from 75% to 76% for some drugs). These changes directly affect Medicare Part D beneficiaries and pharmaceutical companies by altering the negotiation process and pricing caps. The bill modifies existing Medicare drug pricing rules without creating new programs, applying to initial price negotiations beginning in 2028.

Maddy summaryThis bill increases the age limit for children to remain eligible for medical care under the CHAMPVA program from 21 to 26 years old, regardless of marital status. It directly affects the children of veterans who qualify for CHAMPVA benefits. The key provision amends Section 1781(c) of Title 38, U.S. Code, to extend coverage until a child's 26th birthday. This change applies to medical care provided on or after the bill's enactment date. It does not affect children already covered under specific existing provisions of the law.

Maddy summaryThe DRIVE Act of 2025 updates how the Department of Veterans Affairs reimburses veterans for using personal vehicles for VA-related travel. It requires the VA to set mileage reimbursement rates equal to or higher than the federal government’s standard rate for employee travel (currently 41.5 cents per mile), replacing the fixed rate in current law. The bill also mandates that veterans receive these reimbursements within 90 days of submitting a valid claim. This directly affects veterans who travel for VA appointments or services using their personal vehicles.

Maddy summaryThe Supreme Court Ethics, Recusal, and Transparency Act of 2025 would establish a formal code of conduct for Supreme Court justices and require them to disclose gifts and financial interests. It creates procedures for filing complaints about justices' conduct, including a judicial investigation panel to review allegations of misconduct. The bill expands circumstances requiring justices to recuse themselves from cases, such as when they or their family received gifts from parties involved in a case. These provisions aim to increase transparency and accountability in the Supreme Court's operations, with new disclosure requirements for parties and amici curiae in court cases.

Maddy summaryThis bill creates a process for the Secretary of Health and Human Services to determine if brand name drug prices exceed those in five reference countries (Canada, UK, Germany, France, and Japan). If a drug is deemed excessively priced, the government will terminate the manufacturer's exclusivity rights and allow any company to produce a generic version under an open, non-exclusive license with a reasonable royalty. Drug manufacturers must submit detailed annual reports on pricing, costs, and revenues, with penalties for noncompliance. The Secretary will maintain a public database of excessive price determinations and report annually to Congress. This directly impacts brand name drug manufacturers, generic producers, and patients who purchase prescription drugs.

Maddy summaryThis bill amends key anti-discrimination laws (Age Discrimination in Employment Act, Title VII, ADA, and Rehabilitation Act) to change how discrimination claims are proven. It requires workers to show only that age (or race, disability, etc.) was a *motivating factor* for employment decisions - not the *sole* cause - to establish discrimination. Under the new standard, complainants can use any admissible evidence, and courts cannot award damages or reinstatement if an employer proves they would have made the same decision without the discriminatory factor. The law applies to all pending and future claims involving age, race, color, religion, sex, national origin, or disability discrimination in employment.

Maddy summaryThis bill requires Medicare Advantage plans to implement electronic prior authorization systems by 2028 and report detailed transparency data starting in 2027. Plans must publicly disclose approval/denial rates, average processing times (including for appeals), technology use, and other metrics for covered medical services. It mandates 24-hour response standards for expedited requests and routinely approved services, with data collection to analyze access patterns and potential disparities in rural/low-income communities. These changes directly affect Medicare Advantage plans, providers, and seniors enrolled in these plans by standardizing and increasing visibility into prior authorization processes.

Maddy summaryThis bill reauthorizes funding for existing mental health support programs designed to assist law enforcement officers experiencing crisis. It extends the authorization period for these programs from 2020-2024 to 2025-2029 under Section 1001(a)(21) of the 1968 Omnibus Crime Control and Safe Streets Act. The bill directly affects law enforcement officers who access these crisis support services, ensuring continued availability of the established program. It does not create new programs but maintains current funding for existing mental health treatment and support resources for officers.